Regenerative medicine and cell-based approaches to restore pancreatic function.

Area of Science:

• Regenerative Medicine
• Cell Biology
• Pancreatic Physiology

Background:

• Pancreatic pathologies, including diabetes mellitus, chronic pancreatitis, and pancreatic ductal adenocarcinoma, have severe consequences.
• Current type 1 diabetes mellitus treatment relies on exogenous insulin, but cell-based therapies offer superior glycemic control.
• Stem-cell-based approaches show promise for studying exocrine disorders and potentially delaying disease progression.

Purpose of the Study:

• To review progress and challenges in cell-based methods for restoring pancreatic endocrine and exocrine function.
• To highlight strategies for optimizing cell delivery and minimizing immunosuppression.
• To discuss tools and obstacles for generating pancreatic cell surrogates in situ.

Main Methods:

• Focus on cell-based therapeutic strategies for pancreatic restoration.
• Investigate optimization of cell delivery sites.
• Explore encapsulation techniques to reduce immunosuppression requirements.
• Discuss in situ generation of exocrine and beta-cell surrogates.

Main Results:

• Cell-based therapies are being developed to regenerate or replace pancreatic beta cells and restore exocrine function.
• Encapsulation and targeted delivery show potential for improving safety and efficacy.
• Generating functional pancreatic surrogates in situ remains a significant challenge.

Conclusions:

• Cell-based therapies hold promise for treating pancreatic diseases, offering potential for superior glycemic regulation and disease management.
• Overcoming challenges in cell delivery, functional integration, and immunosuppression is crucial for clinical translation.
• Further research is needed to establish standards for bioengineered pancreatic cell therapies.